February is American Heart Month, so we’re going to look at an aspect of behavioural science that can have an impact on outcomes in coronary heart disease (CHD). People act in line with their thoughts and feelings: the Common Sense Model If you have a conversation...

Increasingly, pharma is striving towards true patient centricity and here we explore how patient-focused drug development (PFDD) could have a direct impact on drug safety and adverse event management. The FDA is developing guidance for PFDD with the goal to better...

As people across the world are living under lockdowns to limit the spread of COVID-19, it is crucial to take care of our mental and physical health. During the first lockdown, we developed a 3-pillar approach aimed at helping older adults to keep healthy and active at...

For those of you who may be concerned or hesitant about receiving the COVID-19 vaccine, here’s what has helped our decision-making at Sprout. The only vaccinations to be approved for COVID-19 at the time of writing use the mRNA (messenger ribonucleic acid) method. We...

We believe that successful roll-out of the COVID-19 vaccination will have a bigger impact on most people’s lives than anything else in 2021. Good uptake of the COVID-19 vaccine will be important for bringing the pandemic under control and allowing some normality to...

Sprout Behaviour Change and Sprout Health Outcomes Cited as Among Most Innovative Divisions in 2020 Los Angeles - Sprout Health Solutions was recognized as having two of the most innovative divisions within the healthcare and life sciences industries by PM360, a...

Behavior Science Specialists Restructure Portfolio of Solutions-Based Offerings for Improved Health and Regulatory Success November 30 – London – Sprout Health Solutions, a UK-based global consultancy formerly known as Sprout Behaviour Change, announced their new name...

At Sprout, we know pharmacists can play a pivotal role in improving medication adherence. That was the inspiration behind Pharminder, a new digital tool from health tech pioneers Artilect in New Zealand, that uses person-centered design principles to extend the...

Our co-founder Christina Jackson is one of a panel of industry experts discussing the barriers pharmaceutical companies can benefit from addressing. Her takeaway advice? Pharma needs to take more risks in being transparent with patients. ‘From my experience, pharma is...

Our co-founder Lina Eliasson co-authored a recently published paper highlighting the need for emotional and practical support for families caring for a child with Neuronal Ceroid Lipofuscinosis Type 2 Disease (CLN2), a rare degenerative neurometabolic condition that...

The coronavirus crisis has been a shock to us all – and has meant a sudden and dramatic change in the way we live. Many of us are no longer able to follow the routines that keep us healthy, both mentally and physically, such as exercising and socialising. As health...

Sprout founders Lina Eliasson and Christina Jackson, and Sarah Clifford who recently launched our US office, have all worked on a fascinating new paper on the International Society for Medication Adherence (ESPACOMP) Medication Adherence Reporting Guideline (EMERGE)....

We were very proud to present a poster on our nurse-delivered caregiver support program for Hunter syndrome at the 2019 Connect For Care, an international meeting for rare disease nurses. Hunter syndrome is a very rare inherited metabolic disorder, which can cause a...

Our co-founder, Christina Jackson, has co-authored a newly published paper with academics at King’s College London, reporting on testing a brief screener to prompt discussions about adherence in routine consultations. The team worked with 161 people with type 2...